General

“Article: PP01 Exploring the long non-coding RNA landscape in Juvenile Myelomonocytic Leukemia” has been added to your cart. View cart

Showing 1889–1904 of 2318 results

Article: PP.10 Cyclophosphamide prevents xenogeneic graft-versus-host disease, without abrogating graft-versus-leukemia effects
€3.03 Add to cart
Article: PP.11 Origin and homeostasis of regulatory T cells in chronic Graft-versus-Host Disease
€3.03 Add to cart
Article: PP.12 Analysis of differences in preventive measures after high-dose cyclophosphamide among Belgian stem cell transplant centres
€3.03 Add to cart
Article: PP.13 Improvement of antibody-induced cell death in multiple myeloma
€3.03 Add to cart
Article: PP.14 Immunophenotypic and molecular features of cuplike morphology in AML
€3.03 Add to cart
Article: PP01 CRISPR/Cas9 mediated gene correction for the Wiskott-Aldrich syndrome
€3.03 Add to cart
Article: PP01 Exploring the long non-coding RNA landscape in Juvenile Myelomonocytic Leukemia
€3.03 Add to cart
Article: PP01 Mucosal- associated invariant T cells deficiency in multiple myeloma can be overcome by PD-1 inhibition
€3.03 Add to cart
Article: PP02 Donor specific anti-HLA antibodies and allogeneic hematopoietic stem cell transplantation
€3.03 Add to cart
Article: PP02 Monocentric retrospective study of 138 therapy-related myeloid neoplasms
€3.03 Add to cart
Article: PP02 The histone methyltransferases G9a/GLP: new promising targets for the treatment of multiple myeloma
€3.03 Add to cart
Article: PP03 Amsacrine combined with high dose cytarabine in relapsed/refractory acute myeloid leukemia (rraml)
€3.03 Add to cart
Article: PP03 HLA typing with 11-loci-NGS: benefits in donor selection
€3.03 Add to cart
Article: PP03 The anaphase-promoting-complex/ cyclosome: a new promising target in mantle cell lymphoma and diffuse large B cell lymphoma
€3.03 Add to cart
Article: PP04 Comparison of bone marrow and umbilical cord derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host-disease
€3.03 Add to cart
Article: PP04 Light chain IgLV3-21 is associated with poor prognosis in Chronic Lymphocytic Leukemia patients independently of the presence of heavy chain IgHV3-21
€3.03 Add to cart

Article: PP.10 Cyclophosphamide prevents xenogeneic graft-versus-host disease, without abrogating graft-versus-leukemia effects

Article: PP.11 Origin and homeostasis of regulatory T cells in chronic Graft-versus-Host Disease

Article: PP.12 Analysis of differences in preventive measures after high-dose cyclophosphamide among Belgian stem cell transplant centres

Article: PP.13 Improvement of antibody-induced cell death in multiple myeloma

Article: PP.14 Immunophenotypic and molecular features of cuplike morphology in AML

Article: PP01 CRISPR/Cas9 mediated gene correction for the Wiskott-Aldrich syndrome

Article: PP01 Exploring the long non-coding RNA landscape in Juvenile Myelomonocytic Leukemia

Article: PP01 Mucosal- associated invariant T cells deficiency in multiple myeloma can be overcome by PD-1 inhibition

Article: PP02 Donor specific anti-HLA antibodies and allogeneic hematopoietic stem cell transplantation

Article: PP02 Monocentric retrospective study of 138 therapy-related myeloid neoplasms

Article: PP02 The histone methyltransferases G9a/GLP: new promising targets for the treatment of multiple myeloma

Article: PP03 Amsacrine combined with high dose cytarabine in relapsed/refractory acute myeloid leukemia (rraml)

Article: PP03 HLA typing with 11-loci-NGS: benefits in donor selection

Article: PP03 The anaphase-promoting-complex/ cyclosome: a new promising target in mantle cell lymphoma and diffuse large B cell lymphoma

Article: PP04 Comparison of bone marrow and umbilical cord derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host-disease

Article: PP04 Light chain IgLV3-21 is associated with poor prognosis in Chronic Lymphocytic Leukemia patients independently of the presence of heavy chain IgHV3-21